Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.7398
-0.0138 (-1.83%)
At close: Nov 21, 2025, 4:00 PM EST
0.7398
0.00 (0.00%)
Pre-market: Nov 24, 2025, 8:01 AM EST
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $8.62 million as of November 24, 2025. Its market cap has increased by 76.09% in one year.
Market Cap
8.62M
Enterprise Value
10.10M
1-Year Change
76.09%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $8.62M, a decrease of -75.57%. That is a compound annual growth rate of -29.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 8.62M | 2.02% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
| Oct 29, 2021 | 35.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |